Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine Dosing in Congenital Hypothyroidism
NCT05371262Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- May 2011
- Primary completion
- May 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of levothyroxine sodium in congenital hypothyroidism (CH) (2 arms), sponsored by University of Naples Federico II. Primary endpoints: Neurodevelopmental outcomes at 4 years and Linear Growth at 48 months. Started May 2011; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
congenital hypothyroidism (CH)
Beyond the preview
Go deeper on NCT05371262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05371262.